VTRS - Weak Sales From Lipitor Norvasc Hurt Viatris' Q1 Earnings Lowers Annual Forecast | Benzinga
Thursday, Viatris Inc (NASDAQ:VTRS) reported first-quarter EPS of $0.67, which is in line with the consensus.
The company reported sales of $3.66 billion, missing the consensus of $3.69 billion. Total net sales declined 2% on a reported basis and increased 2% on a divestiture-adjusted operational basis.
Brand sales fell 5% to $2.31 billion. The company says the performance reflects strong growth in Emerging Markets and Europe and expansion of business activities in JANZ, offset by unfavorable channel dynamics in North America and expected base business erosion resulting from government ...